Alzheimer's risk may be 35% lower with common menopause treatment, study finds

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by LSEG. Alzheimer's Association VP Rachel Conant joins 'Fox News Live' to discuss policy hurdles blocking access to breakthrough Alzheimer's treatments. Women who used estrogen-only menopausal hormone therapy (MHT) were less likely to develop Alzheimer’s-related brain changes or dementia, according to a large Stanford study published Aug. 12 in Neurology. The researchers analyzed post-mortem data from 21,462 participants, comparing 258 women who reported estrogen-only MHT use with approximately 2,701 women who reported no MHT use. The researchers examined the brains for signs of Alzheimer’s disease, including amyloid plaques, neurofibrillary tangles and amyloid-plaque density. Plaques and tangles are two hallmark brain changes associated with the common dementia. ALZHEIMER'S BLOOD TESTS MAY PREDICT SYMPTOMS YEARS IN ADVANCE, BUT EXPERTS URGE CAUTION The wome